Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
113 Leser
Artikel bewerten:
(0)

Research and Markets - World Diabetes App Market Report 2016-2021: Top 10 Apps Featuring Abbott, Dexcom, H2, mySugr, Medtronic, MedHelp & Others

DUBLIN, Jan 3, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Diabetes App Market Report 2016-2021" report to their offering.

In 2016, some 423.4M people are expected to suffer from this metabolic disease. This amounts to 8.5% of the entire global adult population, which is expected to reach 642M by 2040. Global annual diabetes-related health expenditure is expected to amount to US$678B, which is estimated to reach US$800.8B. Currently, 12% of today's healthcare expenditure can be related to the treatment of people with diabetes, and 34% of today's global spending on diabetes can be addressed by diabetes app services and products.

Diabetes apps promise to support the treatment and lifestyle changes of people with diabetes by offering:

  • Tracking (e.g. glucose readings and activities).
  • Calculation of insulin dosage.
  • Reminders (e.g. for medication).
  • Connection of patients with coaches, doctors and each other.
  • Education for patients about the disease.
  • Recommendations based on pattern recognition for enabling behavior change.
  • General quality of life improvement.

Top 10 diabetes app solutions to watch out for in the future

  • Abbott with FreeStyle Libre & LibreLink - cutting edge wearable sensor
  • Dexcom with G5 mobile ecosystem - ahead of competitors with device add-on apps
  • H2 Inc. with Health2Sync - high growth from within the Asian market
  • Informed Data Systems Inc. with One Drop for Diabetes Management - a stylish lifestyle solution for people with diabetes
  • mySugr GmbH with mySugr Logbook - promoting positivity amongst people with diabetes
  • Livongo with Livongo for Diabetes - a coaching service for people with diabetes
  • LifeScan Inc. with OneTouch Reveal
  • Medtronic with MiniMed Connect and Sugar I.Q. - healthcare industry giant with its own agenda
  • Glooko with Glooko - clinical data platform
  • MedHelp, Inc. with Sugar Sense - a health & fitness platform

Key Topics Covered:

1 Scope of the report

2 Management summary

3 Addressable target groups and markets for diabetes apps

4 Status of the diabetes app market

5 Download performance of top listed diabetes apps per country in 2016

6 Evolving strategies of diabetes app publishers

7 Competitive landscape of diabetes app publishers

8 Top 10 diabetes app solutions to watch out for in the future

9 Outlook: The next five years to 2021

10 Global market revenue forecast (2016-2021)

11 Appendix

Companies Mentioned

- Abbott
- Dexcom
- FreeStyle Libre
- Glooko
- H2 Inc.
- Livongo
- LifeScan
- Medtronic
- mySugr GmbH

For more information about this report visit http://www.researchandmarkets.com/research/7cmsgq/diabetes_app

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.